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Abstract
Background: In spite of the increasing incidence of total knee arthroplasties (TKA), evidence is limited regarding risk
factors for revision. The objective of this scoping review was to identify and assess demographic, surgical and health
services factors that may increase the risk for revision surgery following TKA.
Methods: A scoping review was undertaken following an electronic search in MEDLINE (1990 to December 2013),
CINAHL (to December 2013), EMBASE (1990 to December 2013) and Web of Science (1990 to December 2013).
Results: Of the 4460 articles screened, 42 were included of which 26 articles were based on registry data. Increased
risk of revision was associated with demographic factors (younger age, African American), surgical factors related to the
primary TKA (uncemented components, implant malalignment, increased surgery duration), and health services
(low volume hospitals).
Conclusions: Identifying emerging trends in characteristics of those requiring revision following TKA can help
identify those at risk and allocate appropriate resources. Further primary clinical articles on risk factors for revision
of TKA are necessary to ensure maximal function and lifespan following TKAs.
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Background
The effectiveness of total knee arthroplasty (TKA) in reliev-
ing pain and improving function has been well documented
[1, 2]. TKA is considered a cost effective and efficacious
treatment for patients with end stage knee osteoarthritis
who experience severe pain, activity limitations and for
whom conservative treatment is unsuccessful [3–5]. With
more than 700 000 primary TKAs performed annually in
the USA, estimates of TKA are projected to increase to
673 % by 2030 in the USA. The large demand for TKA is
primarily related to the aging population, the obesity epi-
demic and technical advancement of the surgical procedure
[6–8]. The longevity of implants is typically greater than
10 years with 32,700 revisions performed annually in the
USA. Significant demand for primary TKA will correspond
to a growing demand for revisions of TKA which are pro-
jected to increase by 601 % from 2005 to 2030 [6].
Revisions for TKA pose unique challenges as revision
surgery is a more complex surgery than a primary TKA
with increased complication and mortality rates [9–11].
Identifying emerging trends in characteristics of those
requiring revision following TKA can help identify those
at risk and allocate appropriate resources. Several arti-
cles have identified risk factors for revision surgery of
TKA yet, to our knowledge, the synthesis of these find-
ings have not been documented. A more comprehensive
understanding of the potential risk factors for revision of
TKA will provide important knowledge for surgeons and
patients. The objective of this scoping review was to
identify and assess demographic, surgical and health
services factors that lead to increased risk of revision
surgery following TKA.
Methods
A scoping review of the literature was undertaken to iden-
tify and assess relevant evidence given the limited existing
evidence on revisions of TKA. Inclusion criteria consisted
of studies that comprised a) adult patients who received
primary TKA and received a subsequent revision, b) com-
parative groups or risk-adjusted analyses, and c) at least
20 or more revision cases. Cohort and case control articles
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were included while descriptive studies and randomized
controlled trials comparing specific interventions were
excluded. Articles which included hemiarthroplasty,
primary TKA used to stabilize a fracture or manage-
ment of bone pathology or malignancy, simultaneous
bilateral TKAs, and patellofemoral arthroplasty were
excluded. Revisions for all reasons were included except
revisions occurring in the first three months due to
sepsis. Ethics was not obtained for this study as the
study was a retrospective scoping review that did not
involve any individual data or identifying information.
In discussion with our Health Research Ethics Board at
the University of Alberta, we do not require ethics for
review.
Data sources and search strategies
A search strategy was developed and implemented by a
health sciences librarian for 4 databases: Medline
(1990-Dec 2013; includes in-process & other non-
indexed citations), EMBASE (1990-Dec 2013), CINAHL
(1990-Dec 2013), and Web of Science (1990-Nov 2012)
(Additional file 1). Date (1990–2013) and language
(English) restrictions were applied to the searches. The
decision to restrict the search to English articles was
based on findings from systematic research evidence
that reported no empirical evidence of bias was seen if
papers written in languages other than English (LOE)
were excluded [12]. The search included an extensive
list of subject headings and keyword terms for 3 con-
cepts: 1) hip or knee arthroplasty, 2) revision surgery,
and 3) prognosis (see Additional file 1). Total hip
arthroplasty articles were included in the search be-
cause we did not want to inadvertently exclude articles
that reported both total hip and total knee arthroplas-
ties. Case articles or case reports were removed along
with conference abstracts. This initial search yielded
many non-relevant papers so an additional search
string was added to increase the relevancy of the results
(by including certain terms in either the title or marked
as the most important subject headings). A “relevancy
forcing search set” was performed to ensure that all rele-
vant papers were captured. All duplicate citations were
removed.
Study selection
To ensure consistency with screening of title and ab-
stract, 20 citations were independently reviewed by both
reviewers (LJ & SP) using a standardized form based on
broad criteria including population intervention, com-
parison, outcome and study design. The remaining cita-
tions were then independently screened for relevance.
If a citation was selected by either reviewer, the full-text
article was obtained for further review. Full-text articles
were further screened for selection using a standard study
selection form, based upon the predetermined inclusion
criteria. The study selection form was initially piloted
on a sample of 20 articles to ensure that the selection
criteria were applied consistently across reviewers.
Relevant full-text articles were then reviewed by one of
the two reviewers using standardized inclusion and
exclusion criteria. Disagreement of article inclusion
was resolved through consensus between reviewers or
through third party adjudication if the reviewers did
not arrive at consensus. Full-text papers were included
only if consensus was achieved by reviewers. For those
articles selected for full review, data were extracted by
one reviewer (LJ) and verified by a second reviewer
(LB or AJ). The first 20 full text articles reviewed by
both reviewers had excellent agreement (Kappa value
0.96, p < 0.0001). All selected articles were included in
data synthesis regardless of methodological quality.
Inconclusive findings and gaps in the literature were
identified. A narrative description of the included articles
was completed and potential patterns identified in terms
of targeted behaviors, study outcomes, and intervention
effectiveness.
Quality assessment
The Oxford Level of Evidence was used to evaluate the
quality of selected full-text articles [13], and has been
recommended to determine a hierarchy of the best evi-
dence [14]. SIGN guidelines were also used to assess
study quality through completion of their cohort check-
list including items such as subject selection, assessment,
confounding and statistical analysis [15].
Results
Of the 4460 articles identified through the search
strategies, 266 articles remained after the abstracts
were screened for eligibility. After full text review, 42
articles met the inclusion criteria for the review (see
Fig. 1). Twenty-six (62 %) articles were based on
registry or insurance databases of which 12 were based on
Nordic registries and 11 from American databases (see
Additional file 2).
All articles were prognostic retrospective articles
with level III quality except for one which was a level
II prognostic prospective study [13, 16]. Using the
SIGN guidelines, 31 articles were regarded of accept-
able quality and 11 articles were deemed poor quality
often due to incomplete reporting of multivariate ana-
lyses (see Additional file 2) [15].
Of the 34 (81 %) articles that reported mean follow-up
from the primary TKA, six articles reported 10 year sur-
vival rates and two articles reported 20 year survival
rates (see Table 1). While survival rates of the primary
TKA were consistently high at 10 years ranging from
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89.5 to 98.6 % [17–19, 20, 21, 42], 20 year survival rates
were expectedly lower at 78–99 % [19, 23].
Demographic risk factors
Sex
While all articles reported sex, the association of sex and
TKA revision was only examined in 10 articles (see Table 2).
Inconsistent findings were reported in that males had a
higher risk of revision surgery than females in 5 articles
(see Table 2), females had a higher risk of revision (HR
1.513, 95 % CI 1.116 to 2.051) in one article, based on
American registry data, [24] and four articles, from differ-
ent countries, did not find a significant association between
sex and TKA revision [16, 18, 25–26].
Fig. 1 PRISMA flow diagram
Table 1 Survival rates at 10 and 20 Yearsa
Author(s), year Duration of follow-up (yrs) Index procedure (n) Revision (n) Survival rate (%, CI)
Badawy M. et al.,
2013 [42]
10 26,698 1169 Low hospital volumeb: 92.5 %, 95 % CI 91.5 to 93.4
High hospital volume: 95.5 %, 95 % CI 94.1 to 97.0
Gothesen, Ø. et al.,
2013 [17]
10 17,782 NR 89.5 to 95.3 %, CI- NR
Himanen, A. et al.,
2007 [20]
10 751 37 Prosthetic moulded component: 94.4 %, 95 % CI 90.4 to 96.7
Prosthetic modular component: 93.6 %, 95 % CI 89.7 to 96.0
Jämsen, E. et al.,
2013 [21]
10 53,007 1919 94.5 %, 95 % CI 94.1 to 94.8
Rand, J. et al.,
2003 [19]
10 11,606 NR 91 %, 95 % CI 90 to 91 %
Vessely, M. et al.,
2006 [18]
10 1000 45 98.6 %, 95 % CI 97.8 to 99.4
Fang, D. et al.,
2009 [23]
20 6070 51 99 %, CI - NR
Rand, J. et al.,
2003 [19]
20 11,606 NR 78 %, 95 % CI 74 to 81 %
aSee Additional file 2 for further detail. Not reported in publication, NR
bLow hospital volume is 1–24 TKA performed per year; High hospital volume is ≥150 TKA performed per year
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Age
Among the 15 articles that examined age as a risk factor,
13 articles reported that revision rates decreased with
older age (see Table 3).
Race
Race was examined in 3 American articles, of which 2 were
based on the same registry [27, 28]. African American
patients had a higher risk for revision than Caucasian
patients (HR 1.73, 95 % CI 1.33 to 2.25, p < 0.001; HR
1.82, 95 % CI 1.33 to 2.48, p < 0.001; HR 1.39, 95 % CI
1.08 to 1.80, p = 0.01) and represented 5.5 and 8.4 % of the
patient population reported in these registries. [27–29].
Medical risk factors
Primary diagnosis
Although the majority of patients undergoing TKA were
diagnosed with osteoarthritis, 4 articles specifically ex-
amined diagnosis and its potential association with TKA
revision with mixed results [19, 24, 25, 30]. Two large
Table 2 Sex and adjusted risk of revisiona
Author(s)/year Control Hazard ratio (CI)
Blum, M. et al.,
2013 [29]
Female 0.81, 95 % CI 0.71 - 0.92, p < 0.01
Fehring, T. et al.,
2004 [52]
Male 2.771, 99 % CI 1.662 - 4.620, p < 0.0001
Harrysson, O. et al.,
2004 [43]
Male 1.64, 95 % CI 1.23 - 2.18, p = 0.0007
Rand, J. et al.,
2003 [19]
Male 1.6, 95 % CI 1.4 - 2.0, p < 0.0001
Schrama, J. et al.,
2010 [30]
Female 0.67, 95 % C I 0.47 - 0.88
Stiehl, J. et al.,
2006 [24]
Female 1.513, 95 % CI 1.116 - 2.051
aSee Additional file 2 for further detail
Table 3 Age and adjusted risk of revisiona
Author(s)/Year Age Hazard ratio (95 % CI)unless otherwise stated
Bini, S. et al.,
2013 [31]
>55 years 0.43, 95 % CI 0.27 to 0.67, p < 0.001
Blum, M. et al.,
2013 [29]
18–64 years vs. 65+ yrs 2.30, 95 % CI 1.96 to 2.69, p < 0.0001
Bordini, B. et al.,
2009 [32]
Age at surgery (per year) 1.05, 95 % CI 1.03 to 1.06, p = 0.0001
Fehring, T. et al.,
2004 [52]
Age at surgery (per year) 0.953, 99 % CI 0.932 to 0.975, p < 0.0001
Gioe, T. et al.,
2004 [53]
Age <70 year 0.46, 95 % CI.0.33 to 0.64, p < 0.001
Harrysson, O. et al.,
2004 [43]
Older patients (≥60 year)
Revision Attributable to Any Reason
Revision Attributable to Loosening of Components
0.49, 95 % CI 0.38 to 0.62, p < 0.0001
0.41, 95 % CI 0.27 to 0.62, p < 0.0001
Julin, J. et al.,
2010 [35]
Age ≤ 55 years:
Revision for reasons other than infection
Revision for any reason
2.9, 95 % CI 2.3 to 3.6
2.4, 95 % CI 2.0 to 3.0 Age 56–65 years
Age 56–65 years:
Revision for reasons other than infection
Revision for any reason :
1.7 95 % CI 1.4 to 2.0
1.5, 95 % CI 1.3 to 1.7
Kreder, H. et al.,
2003 [25]
Younger age per 10 year:
At 1 year after revision
At 3 years after revision
OR 0.77, 95 % CI 0.67 to 0.89
OR 0.70, 95 % CI 0.66 to 0.81
Lygre, S. et al.,
2011 [37]
Age >70 year vs. <60 year 0.4, 95 % CI 0.3–0.4, 0 < 0.001
Namba, R. et al.,
2013 [28]
Age (increasing 10 year increments) 0.62, 95 % CI 0.57 to 0.67, p < 0.001
Namba, R. et al.,
2012 [27]
Age (increasing 10 year increments) 0.64, 95 % CI 0.58 to 0.70, p < 0.001
Rand, J. et al.,
2003 [19]
Age 56–70 year vs. ≤55 years
Age >70 year vs. ≤55 years
0.7, 95 % CI 0.5 to 0.9, p < 0.01
0.5, 95 % CI 0.3 to 0.6, p < 0.0001
Stiehl, J. et al.,
2006 [24]
Younger patients (for every yr increase) 0.979, 95 % CI 0.968 to 0.989
aSee Additional file 2 for further detail
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registry articles reported differing results with inflamma-
tory arthritis having a greater and lesser risk for revi-
sions than patients with osteoarthritis (HR 1.6, 95 % CI
1.06 to 2.38 and HR 0.5, 95 % CI 0.3 to 0.7, p < 0.001)
[19, 30]. A clinical study of 4743 patients found that OA
or post-traumatic arthritis had a greater risk of revision
than RA (HR 1.51, 95 % CI 1.116 to 2.051) [24]. Further,
in a clinical sample of 14352 patients, Kreder et al.
reported no significant association between the diagnosis
of OA and risk for revision [25].
Comorbidities
Eleven articles specifically looked at the effect of co-
morbidities examining both total number of conditions
and specific conditions (see Additional file 2). Jamsen
et al. found that risks increased if there were one or
more of the comorbidities identified (HR 1.23, 95 % CI
1.16 to 1.30) [21]. Alternately, Kreder et al. did not find
a significant association between the presence of co-
morbidities and revision following TKA [25].
When looking at comorbidities associated with OA,
obesity, cardiac disease and diabetes were at high risk
of revision. Two American TKA registries reported in-
creased risk of revision for patients with a higher BMI
(BMI 30–35 kg vs <30 kg HR 1.48, 95 % CI 1.00 to 2.19
and BMI ≥35 kg/m2 vs. <30 kg/m2 h 0.78, 95 % CI 0.63
to 0.96, p = 0.020) [28, 31]. However, 3 other articles
did not find a significant relationship between BMI and
risk for TKA revision [18, 20, 32].
The presence of cardiac conditions at time of the pri-
mary TKA increased the risk of revision including
hypertension with early revision (0 – 5 years) (HR 1.14,
95 % CI 1.01 to 1.29), coronary disease (HR 1.27 95 %
CI 1.07 to 1.50) and cardiovascular disease (HR 1.29,
95 % CI 1.14 to 1.45) [21, 33].
Three articles reported an increased risk of revision
for the patients with diabetes. Jamsen et al. and Namba
both found an association with diabetes and revision
(HR 1.27, 95 % CI 1.08 to 1.50 and HR 1.21, 95 % CI
1.04 to 1.41, p = 0.014) although Jamsen et al. was exam-
ining early revisions [28, 21]. Similarly, King et al. also
found the 46 to 55 years and 66 years + diabetic cohorts
had increased risk of revision as compared to the non-
diabetic cohort (HR 2.9 95 % CI 1.5 to 5.8, p = 0.004 and
HR 1.5, p = 0.0037 respectively) although there was not a
significant difference in the 56 to 65 years cohort [34].
Joint implant factors
Fixation
Two articles consisting of 9337 patients from the US
found cemented primary TKAs had a protective effect
on receiving revision as compared to cementless/hy-
brid TKAs [16, 19]. Hybrid fixation, in which the
proximal component was cementless and the distal
component was cemented, also demonstrated a higher
risk for revision than cemented TKAs in both US and
Norwegian studies [16, 35].
Cruciate retaining implants
Cruciate ligament status was reported in several articles
with inconsistent findings (see Table 4) [16]. Two large
American registry studies reported that posterior stabi-
lized implants had increased risk of revision when com-
pared to posterior cruciate-retaining implants (HR 2.6,
95 % CI 2.1 to 3.5, p < 0.0001 and HR = 2.0, 95 % CI 1.67
to 2.5, p < 0.001) [19, 36]. Conversely, an American
registry study of 1047 patients found ligament status was
not significant [16]. Further, Stiehl et al. found both pos-
terior cruciate retaining arthroplasties and bicruciate
retaining arthroplasties had increased risk of revision
compared to rotating platform (HR 1.552, 95 % CI 1.157
to 2.081 and HR 2.188, 95 % CI 1.454 to 3.294) [24].
Patellar resurfacing
The articles that specifically examined patellar resurfacing
had inconsistent findings. Three articles found that the risk
of revision increased when the patella was resurfaced (pa-
tella not resurfaced HR 1.4, 95 % CI 1.2 to 1.7, patella res-
urfaced HR 0.84, 95 % CI: 0.071–1.0, p = 0.052, and
patellar resurfaced HR 1.814, 95 % CI 1.320 to 2.558 re-
spectively) [24, 35, 37]. Alternately, two articles found that
the patellae not resurfaced patellae had higher risks of revi-
sion than resurfaced patellae (HR 2.09, 95 % CI 1.07 to
4.06, p = 0.03, HR 1.4, 95 % CI 1.2 to 1.7) [27, 35]. Two
studies did not find an association between patellar re-
surfacing and revision significant [20, 38]. One study
reported that metal-backed patella were more likely to
be revised than all polyethylene patellar components
(HR 2.4, 95 % CI 1.9 to 3.1, p < 0.0001) [19].
Alignment
Malalignment was reported to be a large risk factor for
revisions (HR >2.7) in three studies with both varus and
valgus malalignment having a greater risk of revision
[23, 39, 40]. Two American studies reported an in-
creased risk of revision with varus tibial malalignment
(<90°) (HR 10.6, 95 % CI 5.4 to 20.6, p < 0.0001; OR 3.0,
p = 0.04 respectively) [23, 39]. Valgus femoral malalign-
ment also showed an increased risk with ≥8° of valgus
(HR 5.1, 95 % CI 2.8 to 9.5, p < 0.0001) [40].
Bone quality
As bone stock is a key determinant of the type of im-
plant used and possible peri-prosthetic fracture, bone
quality is an important surgical consideration. Only one
study examined bisphosphonate use and reported a
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protective effect for risk for revision (HR 0.40, 95 % CI
0.15 to 1.07, p = 0.068) [41] recommending its use for
those patients with the diagnosis of osteoarthritis.
Health services
Of the 3 articles that reported hospital volume in
Canada, USA and Norway, low volume hospitals had an
increased risk for revision of primary TKAs [25, 42, 22].
The definition of low volume, however, varied from less
than 25 to less than 50 procedures annually. Further,
Harrysson et al. found that the risk of revision decreased
when comparing the year of surgery to the previous year
(HR 0.92, 95 % CI 0.89 to 0.96, p < 0.0001) over a 10 year
time period [43].
Length of surgery for the primary TKA was also found
to have a significant association with revision risk in
TKA primary surgery >240 min (OR 1.34, 95 % CI 1.07
to 1.67, p = 0.012) as compared to <240 min, 150 to
180 min (OR 1.31, 95 % CI 1.09 to 1.57, p = 0.004) as com-
pared to 120 to 150 min and <90 min (OR 1.47, 95 % CI
1.10–1.95, p = 0.008) as compared to 120 to 150 min [44].
Discussion
We identified 42 articles that reported risk factors for
TKA revision using risk-adjusted analyses. Demographic,
Table 4 Implant type/technique and adjusted risk of revisiona
Author(s)/year Implant type/technique Reference Hazard ratio (95 % CI) unless otherwise stated
Abdel, M. et al., 2011 [36] Cruciate Status:
Posterior cruciate-retaining Posterior cruciate-stabilizing 0.5, 95 % CI 0.4 - 0.6, p < 0.001
Rand, J. et al., 2003 [19] Cruciate Status:
Posterior Stabilized Posterior cruciate-retaining 2.6, 95 % CI 2.1 - 3.5, p < 0.0001
Constrained condylar Posterior cruciate-retaining 2.1, 95 % CI 0.9 - 4.9, p = 0.08
Stiehl J. et al., 2006 [24] Cruciate Status
PCRs Rotating platform 1.552, 95 % CI 1.157 - 2.081
BCRs 2.188, 95 % CI 1.454 - 3.294
Gøthesen, O. et al., 2013 [17] Implant Type:
Duracon Profix 2.6, 95 % CI 1.9 - 3.4, p < 0.001
LCS Classic HR 1.3, 95 % CI 1.0 - 1.6, p = 0.017
LCS Complete 1.5, 95 % CI 1.1 - 1.9, p = 0.002
AGC Universal 1.6, 95 % CI 1.3 - 2.0, p < 0.001
Lygre, S. et al., 2010 [37] Implant Type: Relative Risk =
NR Tricon NR AGC Universal 1.67, 95 % CI 1.24–2.24, p = 0.001,
NR Genesis 1 1.43, 95 % CI 1.14–1.79, p = 0.002,
NR Duracon 1.45, 95 % CI 1.05–1.99, p = 002.
NR Profix 0.66, 95 % CI 0.52–0.82, p < 0.001,
NR e.motion 0.09, 95 % CI 0.02–0.37, p = 0.001,
NR AGC anatomic 0.66, 95 % CI 0.45–0.99, p = 0.04,
PR AGC universal 0.48, 95 % CI 0.27–0.83, p = 0.009,
PR NexGen 0.40, 95 % CI 0.22–0.74, p = 0.004.
Namba R. et al., 2013 [28] Implant Type:
Rotate LCS Fixed PS 2.07, 95 % CI 1.53 - 2.80, p < 0.001
High flexion Yes versus No 1.76, 95 % CI 1.29 - 2.41, p < 0.001
Namba R. et al., 2012 [27] Implant Type:
LCS Fixed 2.01, 95 % CI 1.41 - 2.86, p < 0.001
Inacio M. et al., 2013 [54] Bearing or inserts:
CoCr-HXLPE CoCr-CPE NS 1.2, 95 % CI 0.9 - 1.5, p > 0.05
OZ-CPE C0Cr-CPE NS 1.4, 95 % CI 0.3 - 5.9, p > 0.05
Abbreviations: RR relative risk, NS not significant, BCR bicruciate preservation, PCR posterior cruciate retention, (PR) patella resurfaced, (NR) patella non resurfaced,
LCS low contact stress, OZ oxidized zirconium, CoCR cobalt chromium, CPE conventional polyethylene, HXLPE highly crosslinked polyethylene;
aSee Additional file 2 for further detail
Jasper et al. BMC Musculoskeletal Disorders  (2016) 17:182 Page 6 of 9
medical and implant factors were identified as risk
factors for revision of TKA ranging from short-term
(<5 years) to long-term follow-up (20+ years). Risk fac-
tors were derived largely from registry data, which inher-
ently restricts the type of risk factors examined.
Primary TKA has been consistently identified as a suc-
cessful surgery with high survival rates even at 10 and
20 years post-surgery. Others have reported rates of 1.26
revisions per 100 observed component years for TKA as
compared to 1.29 revisions per 100 observed component
years for total hip replacements and 3.29 revisions per
100 component years for total ankle replacements [45].
Given the success of the surgery, it has been suggested
the focus of research should perhaps shift to patient
selection for these procedures to optimize outcomes and
health resources [46].
The trend of increasing revision rates will likely in-
crease [46, 47]. This information was especially rele-
vant given that the 45–64 year old cohort is one of the
fastest growing demographics [48, 49]. Further, this
age cohort demonstrated an increased use of TKA and
will require a longer life expectancy for the TKA, an
important consideration when planning for future allo-
cation of resources [46, 49]. The increased risk for
revision in the younger population must be further
examined to determine if it is indeed age that is the risk
factor or if age is a proxy for higher activity levels or
increased expectations in this younger patient population.
Comorbidities such as diabetes, cardiovascular dis-
ease, hypertension, obesity, cancer and lung disease
were found to increase the risk for revision. These find-
ings are particularly meaningful given the increasing
prevalence of multi-morbidity and the challenge of sur-
gical management of patients with other chronic dis-
eases [50, 51]. Further investigation of management
programs of secondary chronic diseases such as hyper-
tension, obesity and diabetes in patients with primary
TKA is warranted.
Often heterogeneity was found among the reported
results for other risk factors for TKA revision. For ex-
ample, mixed results were reported regarding sex, pri-
mary diagnosis, BMI, patellar resurfacing and implant
components suggesting a need for further investigation.
Some consensus existed, however, regarding cemented
prostheses which had a lower risk of revision than
uncemented or hybrid in spite of an initial goal of
uncemented fixation to decrease complications associ-
ated with aseptic loosening [16, 19, 35]. Increased
surgery length and low hospital volumes were also
found to negatively affect revision rates which is im-
portant information to consider in health resource allo-
cation and planning.
In spite of a wide body of literature published on vari-
ous surgical factors, many articles were of low quality
and few included risk-adjusted analysis. The majority of
included articles (41/42) were retrospective prognostic
articles limiting the quality of the articles to an Oxford
level III. Because the majority of data (26/42) was taken
from registry data, the data were often limited to basic
demographic information such as age, gender and BMI
and did not evaluate pain and functional measures (see
Additional file 2). An inherent limitation of these large,
population-based registries is that demographic, surgical
and health services data over decades have typically been
evaluated and do not provide patient-reported outcomes
or patient-reported experience measures which are central
to clinical outcomes of TKA. Finally, findings were derived
from two geographical populations, 26 in the USA and 11
in Nordic countries. External validity to other populations
is uncertain because of different healthcare systems and
potentially different prostheses.
In spite of an extensive search strategy and a strong
systematic approach to undertaking this systematic
review, identifying risk factors for revision was challen-
ging because of low revision rates in the first 10 years
following surgery. Most articles had follow-up periods
of <10 years which reflected high survival rates of
TKA. Due to these high survival rates, it can be a
lengthy and costly process to undertake studies for the
appropriate duration to acquire accurate information
on revisions. Another consideration is that many early
revisions occurring within 10 years are often related to
surgical techniques and few articles made the distinc-
tion between early and later revisions. Finally, as TKAs
are most often performed on an older population, the
development of other chronic conditions and mortality
poses a challenge to long-term follow-up.
Conclusions
Current literature suggests an increased risk for revi-
sion following TKA is associated with younger age,
greater number of comorbidities, African American
race, uncemented components, increased surgery dur-
ation, and lower volume hospitals. This scoping review
allowed us to identify areas where consistent results
were found but also highlight areas with heterogeneous
results or insufficient data where further research is
required. The findings also demonstrate the need for
large scale and high quality investigations examining
factors that increase the risk for revision following
TKA including patient-reported outcomes and patient-
reported experience measures. Given the increasing
numbers of TKA procedures and revisions, information
on risk factors for revisions following TKAs is neces-
sary for appropriate interventions to be delivered in a
timely manner and for the development of effective
health care policy.
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